Seth M Pollack Selected Research

Leiomyosarcoma

1/2022	A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
2/2021	Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).
11/2016	The Imaging and Pathological Features of Metastatic Leiomyosarcoma in the Gallbladder.
1/2016	Pazopanib in the management of advanced soft tissue sarcomas.
2/2015	Trabectedin in soft tissue sarcomas.
8/2014	Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seth M Pollack Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 01/2011
34	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 01/2011
11	Synovial Sarcoma (Synovioma) 03/2024 - 01/2016
11	Testicular Neoplasms (Testicular Cancer) 01/2022 - 01/2011
7	Myxoid Liposarcoma 03/2024 - 09/2012
6	Leiomyosarcoma 01/2022 - 08/2014
4	Chondrosarcoma 04/2022 - 01/2012
4	Liposarcoma 01/2022 - 02/2015
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2016 - 05/2013
2	Melanoma (Melanoma, Malignant) 01/2022 - 02/2012
2	Adenocarcinoma 07/2019 - 01/2014
2	Adenosarcoma of the uterus 02/2014 - 06/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2010 - 02/2009
1	Glioma (Gliomas) 02/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 04/2022
1	Necrosis 01/2022
1	Disease Progression 01/2021
1	Myocarditis (Carditis) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2019
1	Inflammation (Inflammations) 01/2019
1	Hemangioma (Angioma) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Neutropenia 01/2018
1	Fatigue 01/2018
1	Leukopenia 01/2018
1	Anemia 01/2018
1	Leiomyoma (Uterine Fibroids) 11/2016
1	Adenosarcoma 06/2013
1	Rupture 02/2013
1	Liver Abscess 01/2013
1	Hemorrhage 10/2012
1	Neoplasm Metastasis (Metastasis) 10/2012

Drug/Important Bio-Agent (IBA)

14	AntigensIBA 01/2022 - 01/2011
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 10/2012
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2024 - 09/2017
6	AnthracyclinesIBA 03/2024 - 02/2015
5	VaccinesIBA 11/2020 - 09/2012
4	Neoplasm Antigens (Tumor Antigens)IBA 02/2023 - 01/2014
4	Immune Checkpoint InhibitorsIBA 12/2022 - 10/2018
4	TrabectedinIBA 03/2022 - 06/2013
3	pembrolizumabIBA 01/2021 - 01/2018
3	pazopanib FDA Link 01/2016 - 01/2013
2	Ifosfamide FDA LinkGeneric 03/2024 - 01/2020
2	B7-H1 AntigenIBA 01/2022 - 09/2017
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2022
2	olaratumabIBA 01/2020 - 01/2020
2	NivolumabIBA 01/2020 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 10/2018 - 02/2013
2	ParaffinIBA 09/2017 - 09/2012
2	Angiogenesis InhibitorsIBA 08/2017 - 01/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 01/2013
1	HLA-A Antigens (HLA-A)IBA 03/2024
1	Toll-Like Receptor 4IBA 10/2023
1	bafilomycin A1IBA 02/2023
1	ErbB Receptors (EGF Receptor)IBA 02/2023
1	epidermal growth factor receptor VIIIIBA 02/2023
1	Verteporfin (Visudyne)FDA Link 02/2023
1	2-bromolysergic acid diethylamide (BOL)IBA 01/2023
1	atezolizumabIBA 01/2022
1	avelumabIBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Recombinant ProteinsIBA 11/2020
1	Mesna (Coenzyme M)FDA LinkGeneric 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Amino Acids FDA Link 07/2019
1	InterferonsIBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 10/2018
1	eribulin FDA Link 01/2018
1	Propranolol (Inderal)FDA LinkGeneric 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	Formaldehyde (Formol)FDA Link 09/2017
1	AutoantigensIBA 09/2017
1	Apoptosis Regulatory ProteinsIBA 09/2017
1	Programmed Cell Death 1 ReceptorIBA 09/2017
1	regorafenibIBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Alkylating AgentsIBA 02/2015
1	Aurora Kinase AIBA 08/2014
1	Interleukin-17 (Interleukin 17)IBA 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013

Therapy/Procedure

32	Therapeutics 03/2024 - 01/2011
16	Immunotherapy 04/2024 - 01/2011
11	Drug Therapy (Chemotherapy) 03/2024 - 02/2010
3	Radiotherapy 04/2024 - 04/2022
2	Neoadjuvant Therapy 01/2022 - 01/2014
2	Hematopoietic Stem Cell Transplantation 02/2010 - 02/2009
1	Radioimmunotherapy 04/2024
1	Immunomodulation 10/2023
1	Intravenous Infusions 01/2023
1	Intravenous Administration 01/2020
1	Operative Surgical Procedures 11/2016
1	Cholecystectomy 11/2016
1	Hysterectomy 11/2016
1	Radiofrequency Ablation 05/2013